← back to search

Shaoqin Zheng

Guangzhou University of Chinese Medicine · CN
Area of research
Public Health, Environmental and Occupational Health · Molecular Biology
Research interest
Research interests include Malaria, Artemisinin, Plasmodium falciparum, Piperaquine, Biology, and Medicine.
h-index
citations
247
works
14
NIH funding
primary concept
email

Recent publications

Transient malaria suppression after mass drug administration with artemisinin-piperaquine in a holoendemic, non-isolated region of Togo
Research Square 2026cited by 0position: middledoi
Exploring the Underlying Mechanisms of Qingxing Granules Treating H1N1 Influenza Based on Network Pharmacology and Experimental Validation
Pharmaceuticals 2024cited by 9position: middledoi
Malaria Control by Mass Drug Administration With Artemisinin Plus Piperaquine on Grande Comore Island, Union of Comoros
Open Forum Infectious Diseases 2023cited by 10position: middledoi
A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands
Preventive Medicine Reports 2023cited by 6position: middledoi
The compound artemisinin-hydroxychloroquine ameliorates bleomycin-induced pulmonary fibrosis in rats by inhibiting TGF-β1/Smad2/3 signaling pathway
Pulmonary Pharmacology & Therapeutics 2023cited by 4position: middledoi
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial
International Journal of Antimicrobial Agents 2022cited by 9position: middledoi
Polymorphisms in the K13-Propeller Gene in Artemisinin-Resistant Plasmodium in Mice
Infection and Drug Resistance 2022cited by 3position: firstdoi
China's foreign aid for global poverty alleviation: artemisinin-based combination therapies against malaria in Togo
Global Health Journal 2021cited by 7position: middledoi
Mass Drug Administration With Artemisinin-Piperaquine for the Elimination of Residual Foci of Malaria in São Tomé Island
Frontiers in Medicine 2021cited by 5position: middledoi
Large-scale Artemisinin–Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa
Clinical Infectious Diseases 2018cited by 57position: middledoi
Temporal changes in genetic diversity of msp-1, msp-2, and msp-3 in Plasmodium falciparum isolates from Grande Comore Island after introduction of ACT
Malaria Journal 2018cited by 52position: middledoi
Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine
Malaria Journal 2016cited by 37position: middledoi
Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy
Parasites & Vectors 2015cited by 33position: middledoi
Mass Drug Administration of Artemisinin-piperaquine on High Malaria Epidemic Area
Tropical Medicine and Health 2014cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Changsheng Deng · Guangzhou University of Chinese Medicine12 papers (2014–2024)Jianping Song · Guangzhou University of Chinese Medicine10 papers (2014–2024)Hongying Zhang · Nanchang University7 papers (2016–2023)Yueming Yuan · Guangzhou University of Chinese Medicine6 papers (2022–2026) · 5 papers (2015–2023)Qi Wang · Heilongjiang University of Chinese Medicine5 papers (2014–2021)Qin Xu · Guangzhou University of Chinese Medicine5 papers (2015–2023) · 5 papers (2014–2023)Yuan Liang · Guangzhou University of Chinese Medicine4 papers (2018–2023)Xin‐zhuan Su · Pennsylvania State University4 papers (2015–2023)Guoming Li · Guangzhou University of Chinese Medicine4 papers (2022–2023)Wanting Wu · Guangzhou University of Chinese Medicine4 papers (2018–2023)Mingqiang Li · Southwest University of Science and Technology3 papers (2018–2022)Bo Huang · Guangzhou University of Chinese Medicine3 papers (2015–2018)Zhibing Wu · Shandong University3 papers (2021–2023)Ruixiang Tan · Guangzhou University of Chinese Medicine3 papers (2021–2023)Shiguang Huang · Jinan University3 papers (2015–2018) · 3 papers (2014–2016) · 3 papers (2018–2023)Zhaojia Wang · Guangzhou University of Chinese Medicine2 papers (2022–2023)